{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:12:02Z","timestamp":1756991522551,"version":"3.30.0"},"reference-count":34,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.3201\/eid2907.230198","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T14:03:48Z","timestamp":1686837828000},"source":"Crossref","is-referenced-by-count":3,"title":["Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada"],"prefix":"10.3201","volume":"29","author":[{"given":"Rajesh Abraham","family":"Jacob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah O.","family":"Ajoge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuganya","family":"Nirmalarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altynay","family":"Shigayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael L.","family":"Demian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheridan J.C.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooman","family":"Derakhshani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalees A.","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M.","family":"Panousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed N.","family":"Draia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie","family":"Vermeiren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Smieja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bulir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Smieja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Surette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison J.","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Mubareka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arinjay","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Mossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2907.230198-202306120942-R1","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41598-022-06159-x","article-title":"Understanding the dynamics of SARS-CoV-2 variants of concern in Ontario, Canada: a modeling study.","volume":"12","author":"Layton","year":"2022","journal-title":"Sci Rep"},{"key":"key-10.3201\/eid2907.230198-202306120942-R2","doi-asserted-by":"crossref","unstructured":"Tuite AR, Fisman DN, Odutayo A, Bobos P, Allen V, Bogoch II,  COVID-19 hospitalizations, ICU admissions and deaths associated with the new variants of concern. Science Briefs of the Ontario COVID-19 Science Advisory Table. 2021 Mar 29 [cited 2023 Feb 1]. https:\/\/covid19-sciencetable.ca\/sciencebrief\/covid-19-hospitalizations-icu-admissions-and-deaths-associated-with-the-new-variants-of-concern","DOI":"10.47326\/ocsat.2021.02.18.1.0"},{"key":"key-10.3201\/eid2907.230198-202306120942-R3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape.","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"key-10.3201\/eid2907.230198-202306120942-R4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID\u2019s role in pandemic response.","volume":"3","author":"Khare","year":"2021","journal-title":"China CDC Wkly"},{"key":"key-10.3201\/eid2907.230198-202306120942-R5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cyto.2013.06.001","article-title":"Novel paradigms of innate immune sensing of viral infections.","volume":"63","author":"Hare","year":"2013","journal-title":"Cytokine"},{"key":"key-10.3201\/eid2907.230198-202306120942-R6","doi-asserted-by":"publisher","first-page":"e1008737","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response.","volume":"16","author":"Sa Ribero","year":"2020","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2907.230198-202306120942-R7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis.","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"key-10.3201\/eid2907.230198-202306120942-R8","doi-asserted-by":"publisher","first-page":"e2203760119","DOI":"10.1073\/pnas.2203760119","article-title":"Interferon resistance of emerging SARS-CoV-2 variants.","volume":"119","author":"Guo","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2907.230198-202306120942-R9","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"key-10.3201\/eid2907.230198-202306120942-R10","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3201\/eid2609.201495","article-title":"Isolation, sequence, infectivity, and replication kinetics of severe acute respiratory syndrome coronavirus 2.","volume":"26","author":"Banerjee","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2907.230198-202306120942-R11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/infdis\/jiab578","article-title":"Surface and air contamination with severe acute respiratory syndrome coronavirus 2 from hospitalized coronavirus disease 2019 patients in Toronto, Canada, March\u2013May 2020.","volume":"225","author":"Kotwa","year":"2022","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2907.230198-202306120942-R12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health.","volume":"1","author":"Elbe","year":"2017","journal-title":"Glob Chall"},{"key":"key-10.3201\/eid2907.230198-202306120942-R13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1017\/ice.2021.2","article-title":"Detection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in outpatients: A multicenter comparison of self-collected saline gargle, oral swab, and combined oral-anterior nasal swab to a provider collected nasopharyngeal swab.","volume":"42","author":"Kandel","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid2907.230198-202306120942-R14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness.","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"key-10.3201\/eid2907.230198-202306120942-R15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jama.2021.14797","article-title":"COVID-19 in Canada: experience and response to waves 2 and 3.","volume":"326","author":"Detsky","year":"2021","journal-title":"JAMA"},{"key":"key-10.3201\/eid2907.230198-202306120942-R16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","article-title":"The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"key-10.3201\/eid2907.230198-202306120942-R17","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/1873-3468.14076","article-title":"Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.","volume":"595","author":"Luan","year":"2021","journal-title":"FEBS Lett"},{"key":"key-10.3201\/eid2907.230198-202306120942-R18","doi-asserted-by":"publisher","first-page":"167058","DOI":"10.1016\/j.jmb.2021.167058","article-title":"Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants.","volume":"433","author":"Laffeber","year":"2021","journal-title":"J Mol Biol"},{"key":"key-10.3201\/eid2907.230198-202306120942-R19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.chom.2021.02.020","article-title":"The variant gambit: COVID-19's next move.","volume":"29","author":"Plante","year":"2021","journal-title":"Cell Host Microbe"},{"key":"key-10.3201\/eid2907.230198-202306120942-R20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants.","volume":"22","author":"Tao","year":"2021","journal-title":"Nat Rev Genet"},{"key":"key-10.3201\/eid2907.230198-202306120942-R21","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1126\/science.abc4730","article-title":"Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy.","volume":"369","author":"Gu","year":"2020","journal-title":"Science"},{"key":"key-10.3201\/eid2907.230198-202306120942-R22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","article-title":"Detection of a SARS-CoV-2 variant of concern in South Africa.","volume":"592","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"key-10.3201\/eid2907.230198-202306120942-R23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.","volume":"27","author":"Planas","year":"2021","journal-title":"Nat Med"},{"key":"key-10.3201\/eid2907.230198-202306120942-R24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"key-10.3201\/eid2907.230198-202306120942-R25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41586-021-03471-w","article-title":"Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.","volume":"593","author":"Cele","year":"2021","journal-title":"Nature"},{"key":"key-10.3201\/eid2907.230198-202306120942-R26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.medj.2022.04.002","article-title":"Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.","volume":"3","author":"Banerjee","year":"2022","journal-title":"Med"},{"key":"key-10.3201\/eid2907.230198-202306120942-R27","doi-asserted-by":"publisher","first-page":"102477","DOI":"10.1016\/j.isci.2021.102477","article-title":"Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses.","volume":"24","author":"Banerjee","year":"2021","journal-title":"iScience"},{"key":"key-10.3201\/eid2907.230198-202306120942-R28","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19.","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"key":"key-10.3201\/eid2907.230198-202306120942-R29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: the first line of defense against SARS-CoV-2.","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat Immunol"},{"key":"key-10.3201\/eid2907.230198-202306120942-R30","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.","volume":"1","author":"Chu","year":"2020","journal-title":"Lancet Microbe"},{"key":"key-10.3201\/eid2907.230198-202306120942-R31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1021\/acschembio.0c00875","article-title":"A clinical-stage cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells.","volume":"16","author":"Mellott","year":"2021","journal-title":"ACS Chem Biol"},{"key":"key-10.3201\/eid2907.230198-202306120942-R32","doi-asserted-by":"publisher","first-page":"e0214122","DOI":"10.1128\/mbio.02141-22","article-title":"Genomic epidemiology and serology associated with a SARS-CoV-2 R.1 variant outbreak in New Jersey.","volume":"13","author":"Mathema","year":"2022","journal-title":"MBio"},{"key":"key-10.3201\/eid2907.230198-202306120942-R33","doi-asserted-by":"publisher","first-page":"e0052721","DOI":"10.1128\/JCM.00527-21","article-title":"Evaluation of cell-based and surrogate SARS-CoV-2 neutralization assays.","volume":"59","author":"Sholukh","year":"2021","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2907.230198-202306120942-R34","doi-asserted-by":"publisher","first-page":"e0111021","DOI":"10.1128\/JVI.01110-21","article-title":"Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects.","volume":"96","author":"Lusvarghi","year":"2022","journal-title":"J Virol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/29\/7\/23-0198_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:59:44Z","timestamp":1732989584000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/29\/7\/23-0198_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2907.230198","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}